Nautilus Biotechnology (NAUT) Competitors $0.86 -0.03 (-2.99%) Closing price 03/31/2025 04:00 PM EasternExtended Trading$0.86 +0.00 (+0.35%) As of 03/31/2025 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAUT vs. SENS, LAB, EYPT, ALNT, QTRX, QSI, AEHR, FEIM, MASS, and KEQUShould you be buying Nautilus Biotechnology stock or one of its competitors? The main competitors of Nautilus Biotechnology include Senseonics (SENS), Standard BioTools (LAB), EyePoint Pharmaceuticals (EYPT), Allient (ALNT), Quanterix (QTRX), Quantum-Si (QSI), Aehr Test Systems (AEHR), Frequency Electronics (FEIM), 908 Devices (MASS), and Kewaunee Scientific (KEQU). These companies are all part of the "measuring and control equipment" industry. Nautilus Biotechnology vs. Senseonics Standard BioTools EyePoint Pharmaceuticals Allient Quanterix Quantum-Si Aehr Test Systems Frequency Electronics 908 Devices Kewaunee Scientific Nautilus Biotechnology (NASDAQ:NAUT) and Senseonics (NYSE:SENS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations. Does the MarketBeat Community favor NAUT or SENS? Nautilus Biotechnology and Senseonics both received 4 outperform votes by MarketBeat users. However, 18.18% of users gave Nautilus Biotechnology an outperform vote while only 10.81% of users gave Senseonics an outperform vote. CompanyUnderperformOutperformNautilus BiotechnologyOutperform Votes418.18%Underperform Votes1881.82% SenseonicsOutperform Votes410.81%Underperform Votes3389.19% Which has better valuation & earnings, NAUT or SENS? Senseonics has higher revenue and earnings than Nautilus Biotechnology. Senseonics is trading at a lower price-to-earnings ratio than Nautilus Biotechnology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNautilus BiotechnologyN/AN/A-$63.67M-$0.56-1.54Senseonics$22.47M19.03-$60.39M-$0.12-5.47 Do analysts rate NAUT or SENS? Nautilus Biotechnology currently has a consensus price target of $2.42, indicating a potential upside of 180.68%. Senseonics has a consensus price target of $2.00, indicating a potential upside of 204.83%. Given Senseonics' stronger consensus rating and higher probable upside, analysts plainly believe Senseonics is more favorable than Nautilus Biotechnology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nautilus Biotechnology 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Senseonics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is NAUT or SENS more profitable? Nautilus Biotechnology has a net margin of 0.00% compared to Senseonics' net margin of -362.30%. Nautilus Biotechnology's return on equity of -28.85% beat Senseonics' return on equity.Company Net Margins Return on Equity Return on Assets Nautilus BiotechnologyN/A -28.85% -24.93% Senseonics -362.30%-842.25%-67.99% Does the media prefer NAUT or SENS? In the previous week, Nautilus Biotechnology had 3 more articles in the media than Senseonics. MarketBeat recorded 4 mentions for Nautilus Biotechnology and 1 mentions for Senseonics. Senseonics' average media sentiment score of 0.67 beat Nautilus Biotechnology's score of 0.29 indicating that Senseonics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nautilus Biotechnology 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Senseonics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders believe in NAUT or SENS? 50.7% of Nautilus Biotechnology shares are owned by institutional investors. Comparatively, 12.4% of Senseonics shares are owned by institutional investors. 40.5% of Nautilus Biotechnology shares are owned by insiders. Comparatively, 3.6% of Senseonics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, NAUT or SENS? Nautilus Biotechnology has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500. Comparatively, Senseonics has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. SummaryNautilus Biotechnology beats Senseonics on 9 of the 15 factors compared between the two stocks. Remove Ads Get Nautilus Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for NAUT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAUT vs. The Competition Export to ExcelMetricNautilus BiotechnologyAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$108.61M$4.49B$5.63B$7.79BDividend YieldN/A0.52%5.34%4.05%P/E Ratio-1.5426.1123.6418.68Price / SalesN/A4.36371.2589.80Price / CashN/A36.2838.1734.64Price / Book0.411.716.734.12Net Income-$63.67M-$83.57M$3.20B$247.10M7 Day Performance-6.45%-6.83%-4.57%-3.13%1 Month Performance-33.77%-13.87%-0.22%-6.21%1 Year Performance-71.30%-36.53%7.96%-1.58% Nautilus Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAUTNautilus Biotechnology2.6653 of 5 stars$0.86-3.0%$2.42+180.7%-70.7%$108.61MN/A-1.54130Short Interest ↑News CoverageSENSSenseonics1.4484 of 5 stars$0.75+0.9%$2.00+167.7%+23.5%$486.93M$22.47M-5.7590Gap DownLABStandard BioTools3.0556 of 5 stars$1.15-5.0%$2.88+150.0%-60.1%$435.83M$174.43M-1.62620Positive NewsEYPTEyePoint Pharmaceuticals1.8357 of 5 stars$6.34+1.4%$26.63+320.0%-73.8%$435.74M$43.27M-3.17120Positive NewsGap DownALNTAllient4.5877 of 5 stars$24.12+1.3%$31.00+28.5%-38.4%$406.30M$529.97M27.411,950Short Interest ↓Positive NewsQTRXQuanterix2.7972 of 5 stars$7.19-0.4%$20.75+188.6%-72.4%$278.80M$135.44M-6.78460Short Interest ↓Gap DownQSIQuantum-Si2.9413 of 5 stars$1.48+1.7%$3.48+134.8%-39.1%$271.05M$3.06M-2.31150Gap UpAEHRAehr Test Systems3.3823 of 5 stars$9.06+1.8%$25.00+175.9%-41.2%$269.19M$50.74M12.0890Upcoming EarningsGap DownFEIMFrequency Electronics2.3701 of 5 stars$16.68+2.6%N/A+43.7%$161.41M$65.40M20.34200MASS908 Devices2.2546 of 5 stars$4.24-6.4%$5.33+25.8%-40.7%$149.80M$59.63M-2.4060Short Interest ↑Gap DownKEQUKewaunee Scientific2.948 of 5 stars$44.96-3.3%N/A+14.5%$128.36M$220.03M7.131,006Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies SENS Competitors LAB Competitors EYPT Competitors ALNT Competitors QTRX Competitors QSI Competitors AEHR Competitors FEIM Competitors MASS Competitors KEQU Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAUT) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nautilus Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nautilus Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NAUT Stock Free NAUT Stock Alerts